Search for: "Singulair MSD" Results 1 - 1 of 1
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Italian Court of Appeal awards EUR 1,5 mio damages in pharma patent case for 40 days infringement
30 Jun 2020, 9:36 am by Roberto A. Jacchia (De Berti Jacchia Franchini Forlani)
More particularly, at the time of launch, the remaining life of MSD’s patent EP ‘480717, as extended by Italian supplementary protection certificate CPC-UB99CC647, protecting medicine Singulair (Montelukast) was only 40 days. [read post]
Kluwer Patent Blog - http://patentblog.kluweriplaw.com/